Bappenas Head Urges Bio Farma to Continue Producing WHO-Standard Vaccines
Jakarta (ANTARA) - The Minister of National Development Planning/Head of the National Development Planning Agency (PPN/Bappenas), Rachmat Pambudy, has requested that Bio Farma undertake modernisation efforts to ensure the continuous production of vaccines using the latest technology that meets World Health Organization (WHO) standards.
“Bio Farma needs to continue modernising so that it is capable of producing vaccines with the latest technology that meets WHO standards, ensuring that vaccine production quality meets not only national standards but also internationally recognised global standards,” he stated during an audience with the President Director of PT Bio Farma, Shadiq Akasya, in Jakarta on Monday.
Minister Rachmat Pambudy reaffirmed his support for the sustainability of the Cervical Cancer Elimination Programme, which has been implemented by Bio Farma in collaboration with the Ministry of Health and international partners since 2016. The programme was expanded into a national initiative in 2023 and will continue until 2030, including the provision of the Human Papillomavirus (HPV) vaccine for school-aged children.
“In essence, we support this programme because it is the duty and mandate of the President to realise a healthier Indonesian society,” said the Head of Bappenas.
Furthermore, the Minister of PPN emphasised the importance of strengthening vaccine production capacity, which has a direct impact on public health, such as polio and HPV vaccines. This must be accompanied by the modernisation of facilities and production processes to meet global quality standards.
In line with this, Bio Farma presented a proposal for the construction of new vaccine production facilities as part of an effort to modernise the national vaccine industry, which is proposed to become a National Strategic Project (PSN).
This new facility is expected to support the implementation of more advanced vaccine production technologies, meet international standards, and strengthen Indonesia’s ability to produce vaccines independently. Such modernisation is considered vital to maintaining the competitiveness of the national vaccine industry and strengthening Indonesia’s future health resilience.
“The success of a National Strategic Project is determined not only by its planning but also by the quality of its execution and completion. Therefore, it must be well-planned, well-executed, and well-completed,” said the Minister of PPN.
Source: jawawa.id (https://jawawa.id/newsitem/bappenas-head-urges-bio-farma-to-continue-producing-who-standard-vaccines-1781520956)
Originally published by Antara (Indonesian) (https://www.antaranews.com/berita/5608964/kepala-bappenas-minta-bio-farma-terus-hasilkan-vaksin-berstandar-who), translated from Indonesian